A Phase IIIB expanded access study of INC424 in myelofibrosis

• Research type

  Research Study

• Full title

  An open-label, multicenter, expanded access study of INC424 for patients with primary myelofibrosis (PMF), or post polycythemia myelofibrosis (PPV MF) or post-essential thrombocythemia myelofibrosis (PET-MF)

• IRAS ID

  80194

• Contact name

  Adam Mead

• Contact email

  adam.mead@imm.ox.ac.uk

• Sponsor organisation

  Novartis Pharma AG

• Eudract number

  2010-024473-39

• ISRCTN Number

  N/A

• Clinicaltrials.gov Identifier

  N/A

• Research summary

  Research summary not published at request of researcher

• REC name

  South Central - Oxford C Research Ethics Committee

• REC reference

  11/SC/0245

• Date of REC Opinion

  12 Aug 2011

• REC opinion

  Further Information Favourable Opinion